|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/221 | (2006.01) |
| A61K 31/222 | (2006.01) | ||
| A61K 31/223 | (2006.01) | ||
| A61K 31/225 | (2006.01) | ||
| A61K 31/255 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| G01N 33/52 | (2006.01) |
| (11) | Patento numeris | 3829568 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19752609.8 |
| Europos patento paraiškos padavimo data | 2019-07-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-06-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data | 2023-12-27 |
| (86) | Numeris | PCT/US2019/044114 |
| Data | 2019-07-30 |
| (87) | Numeris | WO 2020/028348 |
| Data | 2020-02-06 |
| (30) | Numeris | Data | Šalis |
| 201862713056 P | 2018-08-01 | US |
| (72) |
KOCIS, Petr , US
HEY, John , US
TOLAR, Martin , US
|
| (73) |
Alzheon, Inc. ,
111 Speen Street
Suite 306, Framingham, MA 01701,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Sulfopropano rūgšties dariniai, skirti neurodegeneraciniams sutrikimams gydyti |
| SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-06-23 | 7 | 162.00 EUR |
| 2026-07-30 |